Ausgabe 1/2012
Inhalt (33 Artikel)
Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literature
Adva Avisar, Yaron River, Elad Schiff, Gil Bar-Sela, Mariana Steiner, Eran Ben-Arye
The Piper Fatigue Scale-12 (PFS-12): psychometric findings and item reduction in a cohort of breast cancer survivors
Bryce B. Reeve, Angela M. Stover, Catherine M. Alfano, Ashley Wilder Smith, Rachel Ballard-Barbash, Leslie Bernstein, Anne McTiernan, Kathy B. Baumgartner, Barbara F. Piper
Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation
Nivedita Banerjee, Stephen Talcott, Stephen Safe, Susanne U. Mertens-Talcott
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer
Esther H. Lips, Rita A. Mukhtar, Christina Yau, Jorma J. de Ronde, Chad Livasy, Lisa A. Carey, Claudette E. Loo, Marie-Jeanne T. F. D. Vrancken-Peeters, Gabe S. Sonke, Donald A. Berry, Laura J. van‘t Veer, Laura J. Esserman, Jelle Wesseling, Sjoerd Rodenhuis, E. Shelley Hwang
Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells
Joomin Lee, Anuradha Sehrawat, Shivendra V. Singh
Role of ornithine decarboxylase in regulation of estrogen receptor alpha expression and growth in human breast cancer cells
Qingsong Zhu, Lihua Jin, Robert A. Casero, Nancy E. Davidson, Yi Huang
Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer
Veronique M. Neumeister, Catherine A. Sullivan, Robert Lindner, Kimberley Lezon-Geyda, Jia Li, Jan Zavada, Maritza Martel, Peter M. Glazer, David P. Tuck, David L. Rimm, Lyndsay Harris
Deep sequencing reveals small RNA characterization of invasive micropapillary carcinomas of the breast
Shuai Li, Cuicui Yang, Lili Zhai, Wenwei Zhang, Jing Yu, Feng Gu, Ronggang Lang, Yu Fan, Meihua Gong, Xiuqing Zhang, Li Fu
Recombinant viral protein VP1 suppresses HER-2 expression and migration/metastasis of breast cancer
Shao-Wen Hung, Ching-Feng Chiu, Tai-An Chen, Chiao-Li Chu, Chi-Chang Huang, Lie-Fen Shyur, Chi-Ming Liang, Shu-Mei Liang
Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients
Naofumi Oda, Kenzo Shimazu, Yasuto Naoi, Koji Morimoto, Atsushi Shimomura, Masashi Shimoda, Naofumi Kagara, Naomi Maruyama, Seung Jin Kim, Shinzaburo Noguchi
Further evidence for a role of tumor CD200 expression in breast cancer metastasis: decreased metastasis in CD200R1KO mice or using CD200-silenced EMT6
Anna Podnos, David A. Clark, Nuray Erin, Kai Yu, Reginald M. Gorczynski
Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer
Long Chen, Jane E. Dahlstrom, Arin Chandra, Philip Board, Danny Rangasamy
A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer
J. Vardy, G. Pond, A. Dodd, D. Warr, B. Seruga, M. Clemons, L. Bordeleau, P. Goodwin, I. F. Tannock
Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype
Nils D. Arvold, Kevin S. Oh, Andrzej Niemierko, Alphonse G. Taghian, Nancy U. Lin, Rita F. Abi-Raad, Meera Sreedhara, Jay R. Harris, Brian M. Alexander
GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients
Mary Anne Quintayo, Alison F. Munro, Jeremy Thomas, Ian H. Kunkler, Wilma Jack, Gillian R. Kerr, J. M. Dixon, Udi Chetty, John M. S. Bartlett
Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics
Erica L. Mayer, Steven J. Isakoff, Giannoula Klement, Sean R. Downing, Wendy Y. Chen, Keri Hannagan, Rebecca Gelman, Eric P. Winer, Harold J. Burstein
Impact of biomarkers on clinical trial risk in breast cancer
Jayson L. Parker, Nadia Lushina, Prabjot S. Bal, Teresa Petrella, Rebecca Dent, Gilberto Lopes
Effect of a mixed solution of sodium hyaluronate and carboxymethyl cellulose on upper limb dysfunction after total mastectomy: a double-blind, randomized clinical trial
Eun Joo Yang, Eunyoung Kang, Jin Youn Jang, Dongwon Kim, Cha Kyong Yom, Jae-Young Lim, Sung-Won Kim
Pre-diagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study
Alina Vrieling, Katharina Buck, Judith Heinz, Nadia Obi, Axel Benner, Dieter Flesch-Janys, Jenny Chang-Claude
Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population
M. Chan, S. M. Ji, C. S. Liaw, Y. S. Yap, H. Y. Law, C. S. Yoon, C. Y. Wong, W. S. Yong, N. S. Wong, R. Ng, K. W. Ong, P. Madhukumar, C. L. Oey, P. H. Tan, H. H. Li, P. Ang, G. H. Ho, A. S. G. Lee
Cost effectiveness of new breast cancer radiotherapy technologies in diverse populations
Heather Taffet Gold, Mary Katherine Hayes
The association between polymorphisms in the leptin receptor gene and risk of breast cancer: a systematic review and pooled analysis
Li-qiang Wang, Wei Shen, Lan Xu, Min-Bin Chen, Ting Gong, Pei-Hua Lu, Guo-Qing Tao
Genetic polymorphisms in centrobin and Nek2 are associated with breast cancer susceptibility in a Chinese Han population
Hui Wang, Yun-Tao Xie, Ji-Yuan Han, Yuan Ruan, Ai-Ping Song, Li-Yuan Zheng, Wei-Zao Zhang, Constantin Sajdik, Yan Li, Xin-Xia Tian, Wei-Gang Fang
Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence
Carolyn L. Smith, Ilenia Migliaccio, Vaishali Chaubal, Meng-Fen Wu, Margaret C. Pace, Ryan Hartmaier, Shiming Jiang, Dean P. Edwards, M. Carolina Gutiérrez, Susan G. Hilsenbeck, Steffi Oesterreich
Exposure to polychlorinated biphenyl (PCB) congeners measured shortly after giving birth and subsequent risk of maternal breast cancer before age 50
Barbara A. Cohn, Mary Beth Terry, Marj Plumb, Piera M. Cirillo
Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women
Kimberly A. Bertrand, A. Heather Eliassen, Susan E. Hankinson, Gretchen L. Gierach, Xia Xu, Bernard Rosner, Regina G. Ziegler, Rulla M. Tamimi
Management of small HER2 overexpressing tumours
Arnoud Templeton, Alberto Ocaña, Boštjan Šeruga, Francisco Vera-Badillo, Lindsay Carlsson, Philippe Bedard, Eitan Amir
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers
Kristen N. Stevens, Xianshu Wang, Zachary Fredericksen, Vernon S. Pankratz, Mark H. Greene, Irene L. Andrulis, Mads Thomassen, Maria Caligo, Katherine L. Nathanson, Anna Jakubowska, Ana Osorio, Ute Hamann, Andrew K. Godwin, Dominique Stoppa-Lyonnet, Melissa Southey, Saundra S. Buys, Christian F. Singer, Thomas V. O. Hansen, Adalgeir Arason, Kenneth Offit, Marion Piedmonte, Marco Montagna, Evgeny Imyanitov, Laima Tihomirova, Lara Sucheston, Mary Beattie, Susan L. Neuhausen, Csilla I. Szabo, Jacques Simard, Amanda B. Spurdle, Sue Healey, Xiaoqing Chen, Timothy R. Rebbeck, Douglas F. Easton, Georgia Chenevix-Trench, Antonis C. Antoniou, Fergus J. Couch
Comment on the review by Joshi and Buehring
James F. Holland, Beatriz G.-T. Pogo
Dietary calcium intake, vitamin D levels, and breast cancer risk: a dose–response analysis of observational studies
Zhiqiang Hong, Changwei Tian, Xingliang Zhang
Non-random distribution of breast cancer susceptibility loci on human chromosomes
Khyber Saify, Mostafa Saadat
A modified technology could significantly improve the visualization rate of the internal mammary sentinel lymph nodes in breast cancer patients
Peng-fei Qiu, Juan-juan Liu, Yan-bing Liu, Guo-ren Yang, Xiao Sun, Yong-sheng Wang